Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology


Atlas Hires Senior Technical Consultant

Atlas Material Testing Technology (Chicago, IL, http://www.atlas-mts.com/) named David Dumbleton its senior technical consultant for the newly created Atlas Consulting Group. Dumbleton will lend his expertise in environmental durability and performance to Atlas's customers and expand the North American consultingservices group.

Dumbleton's experience includes technical and business management in the polymer-materials industry. He previously worked as a director of research and development at Alcoa Flexible Packaging.

Expansions

BASF Adds THF Capacity at Ludwigshafen Site

BASF (Florham Park, NJ http://www.basf.com/) is expanding its annual capacity for the intermediate tetrahydrofuran (THF) by 30, 000 tons at its Ludwigshafen site. The expansion will raise the company's annual THF capacity to 210, 000 metric tons by the end of 2007.

THF is used in complex water-sensitive reactions frequently needed to produce active pharmaceutical ingredients. BASF supplies high-purity THF with a low residual water content of 0.01%.

Future Pak Moves to Larger Facility

Future Pak Ltd. (Wixom, MI, http://www.futurepak.com/), a contract packager, moved its solid-dose packaging operations to a new location. Three blister suites, 12 form–fill–seal lines, and soliddose bottling operations moved to a 32, 000-ft2 facility in Wixom, Michigan.

The site will provide space for the expansion of the company's blister-packaging capacity. During the past three years, Future Pak's annual packaging volume grew to 1800 batches, or about 7 billion tablets.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here